Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does DOXORUBICIN Cause Gastrointestinal toxicity? 242 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 242 reports of Gastrointestinal toxicity have been filed in association with DOXORUBICIN (Doxorubicin Hydrochloride). This represents 0.3% of all adverse event reports for DOXORUBICIN.

242
Reports of Gastrointestinal toxicity with DOXORUBICIN
0.3%
of all DOXORUBICIN reports
59
Deaths
37
Hospitalizations

How Dangerous Is Gastrointestinal toxicity From DOXORUBICIN?

Of the 242 reports, 59 (24.4%) resulted in death, 37 (15.3%) required hospitalization, and 21 (8.7%) were considered life-threatening.

Is Gastrointestinal toxicity Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for DOXORUBICIN. However, 242 reports have been filed with the FAERS database.

What Other Side Effects Does DOXORUBICIN Cause?

Febrile neutropenia (8,844) Off label use (7,858) Disease progression (6,165) Neutropenia (5,891) Drug ineffective (4,598) Pyrexia (3,697) Thrombocytopenia (3,638) Anaemia (3,601) Product use in unapproved indication (3,502) Nausea (2,925)

What Other Drugs Cause Gastrointestinal toxicity?

CAPECITABINE (368) FLUOROURACIL (358) METHOTREXATE (345) OXALIPLATIN (314) CYCLOPHOSPHAMIDE (266) RITUXIMAB (262) CISPLATIN (251) IRINOTECAN (232) CARBOPLATIN (231) BORTEZOMIB (208)

Which DOXORUBICIN Alternatives Have Lower Gastrointestinal toxicity Risk?

DOXORUBICIN vs DOXYCYCLINE DOXORUBICIN vs DOXYCYCLINE HYCLATE DOXORUBICIN vs DOXYCYCLINE\DOXYCYCLINE HYCLATE DOXORUBICIN vs DOXYLAMINE DOXORUBICIN vs DOXYLAMINE\PYRIDOXINE

Related Pages

DOXORUBICIN Full Profile All Gastrointestinal toxicity Reports All Drugs Causing Gastrointestinal toxicity DOXORUBICIN Demographics